SCHEMBL4303699

SCHEMBL4303699

COCc1cc(N(C)C)ccc1C(N)=S

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.38
HPGD P15428 3/20 0.38
RAD52 P43351 1/20 0.38
MAPT P10636 4/20 0.37
GAA P10253 3/20 0.37
KMT2A Q03164 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MAOA P21397 3/20 0.33
APP P05067 2/20 0.33
TSHR P16473 2/20 0.33
MAOB P27338 2/20 0.33
CALM1 P0DP23 1/20 0.33
KDM4E B2RXH2 2/20 0.33
USP2 O75604 1/20 0.33
PKM P14618 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PTGS1 P23219 1/20 0.33
KLKB1 P03952 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4302585 0.82 PSMB5 (0.41) ALDH1A1HPGDRAD52MAPTGAA
SCHEMBL4304926 0.80 ALDH1A1 (0.41) ALDH1A1HPGDMAPTKMT2ATSHR
SCHEMBL4301042 0.76 ALDH1A1 (0.67) ALDH1A1HPGDRAD52MAPTGAA
SCHEMBL14501770 0.73 ALDH1A1 (0.37) ALDH1A1HPGDMAPTGAAMAOA
SCHEMBL4301391 0.73 ALDH1A1 (0.43) ALDH1A1HPGDRAD52MAPTGAA
SCHEMBL4300593 0.72 ALDH1A1 (0.41) ALDH1A1HPGDRAD52MAPTGAA
SCHEMBL4303343 0.71 ALDH1A1 (0.42) ALDH1A1HPGDRAD52MAPTGAA
SCHEMBL22897931 0.71 ALDH1A1 (0.39) ALDH1A1HPGDMAPTGAAKMT2A
SCHEMBL4306068 0.71 ALDH1A1 (0.42) ALDH1A1HPGDRAD52MAPTGAA
SCHEMBL4296083 0.71 ALDH1A1 (0.36) ALDH1A1HPGDMAPTGAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270363-A1 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof WYETH (US) 2009-10-29 US disclosed
US-20090270363-A1 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof WYETH (US) 2009-10-29 US disclosed
US-20090270363-A1 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof WYETH (US) 2009-10-29 US disclosed
WO-2009120826-A1 2-ARYL- AND 2-HETEROARYLTHIAZOLYL COMPOUNDS, METHODS FOR THEIR PREPARATION AND USE THEREOF WYETH (US) 2009-10-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270363-A1 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof SEC63, SEC62, SEC22B ALDH1A1 2705/4885HPGD 2554/4885RAD52 2916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.